3-氯-1-(2-氟苯基)-1-丙酮 | 898767-04-9

• 分子结构分类: 有机化合物 - 有机氧化合物
• 中文名称: 3-氯-1-(2-氟苯基)-1-丙酮
• 英文名称: 3-chloro-1-(2-fluorophenyl)propan-1-one
• CAS: 898767-04-9
• 化学式: C₉H₈ClFO
• mdl: MFCD07699515
• 分子量: 186.613
• InChiKey: WCNSDVGUYXGZDE-UHFFFAOYSA-N

物化性质

• 沸点：
  265.0±20.0 °C(Predicted)
• 密度：
  1.219±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.2
• 重原子数：
  12
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.222
• 拓扑面积：
  17.1
• 氢给体数：
  0
• 氢受体数：
  2

安全信息

• 海关编码：
  2914700090
• 危险性防范说明：
  P280,P305+P351+P338
• 危险性描述：
  H317,H319

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 3-Chloro-1-(2-fluorophenyl)propan-1-one
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 3-Chloro-1-(2-fluorophenyl)propan-1-one
CAS number: 898767-04-9

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C9H8ClFO
Molecular weight: 186.6

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, hydrogen chloride, hydrogen fluoride.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  3-氯-1-(2-氟苯基)-1-丙酮 在 三乙胺 作用下， 以 二氯甲烷 为溶剂， 反应 3.0h， 生成 1-(2-氟苯基)丙-2-烯-1-酮
  参考文献：
  名称：

  通过分支选择性 Pd/Cu 催化的烯丙基取代对简单二羧酸盐进行立体发散去对称化。

  摘要：

  不对称去对称化已被证明是在不对称合成中构建立体中心的有力策略。本文报道了 Pd/Cu 催化的不对称去对称化反应与简单的偕二羧酸盐。带有芳基或杂芳基的多种亚氨基酯与这种双金属催化体系相容。反应顺利进行，以良好的收率得到所需的产物，具有高至优异的区域选择性、非对映选择性和对映选择性（高达 20:1 的支链：线性，>20:1 dr，>99 % ee）。值得注意的是，该反应有利于支链选择性，这对于 Pd 催化的烯丙基烷基化反应是不寻常的。此外，标准产品可以很容易地转化为其他有价值的分子，例如手性烯丙醇、氨基甲酸酯和有机硼化合物。

  DOI：

  10.1002/chem.202200273
• 作为产物：
  描述：

  邻氟苯甲酸 在 三氯化铝 、 氯化亚砜 作用下， 以 1,2-二氯乙烷 、 苯 为溶剂， 生成 3-氯-1-(2-氟苯基)-1-丙酮
  参考文献：
  名称：

  A Convenient Synthesis of 7-Halo-1-indanones and 8-Halo-1-tetralones

  摘要：

  A regioselective oxidation of N-indan-4-yl-acetamide or N-(5,6,7,8-tetrahydronaphthalen-1-yl)acetamide with potassium permanganate followed by acidic hydrolysis gave 7-aminoindan-1-one or 8-aminotetral-1-one in good yield. The amino ketones were converted to the corresponding 7-haloindanone or the 8-halotetralone. Another method to prepare 7-haloindan-1-ones was completed by a cyclization of 3-chloro-1-(2-halophenyl)propan-1-one under Friedel-Crafts conditions to produce the product in gram quantity.

  DOI：

  10.1021/jo035289s

文献信息

• [EN] ISOXAZOLIDINE DERIVED INHIBITORS OF RECEPTOR INTERACTING PROTEIN KINASE 1 (RIPK 1)<br/>[FR] INHIBITEURS DÉRIVÉS D'ISOXAZOLIDINE DE PROTÉINE KINASE 1 INTERAGISSANT AVEC UN RÉCEPTEUR (RIPK 1)
  申请人：DENALI THERAPEUTICS INC

  公开号：WO2017096301A1

  公开（公告）日：2017-06-08

  The present disclosure relates generally to methods and compositions for preventing or arresting cell death and/or inflammation.

  本公开涉及一般用于预防或阻止细胞死亡和/或炎症的方法和组合物。
• Structure-Based Design and Synthesis of 1,3-Oxazinan-2-one Inhibitors of 11β-Hydroxysteroid Dehydrogenase Type 1
  作者：Zhenrong Xu、Colin M. Tice、Wei Zhao、Salvacion Cacatian、Yuan-Jie Ye、Suresh B. Singh、Peter Lindblom、Brian M. McKeever、Paula M. Krosky、Barbara A. Kruk、Jennifer Berbaum、Richard K. Harrison、Judith A. Johnson、Yuri Bukhtiyarov、Reshma Panemangalore、Boyd B. Scott、Yi Zhao、Joseph G. Bruno、Jennifer Togias、Joan Guo、Rong Guo、Patrick J. Carroll、Gerard M. McGeehan、Linghang Zhuang、Wei He、David A. Claremon

  DOI：10.1021/jm2005354

  日期：2011.9.8

  Structure based design led directly to 1,3-oxazinan-2-one 9a with an IC50 of 42 nM against 11β-HSD1 in vitro. Optimization of 9a for improved in vitro enzymatic and cellular potency afforded 25f with IC50 values of 0.8 nM for the enzyme and 2.5 nM in adipocytes. In addition, 25f has 94% oral bioavailability in rat and >1000× selectivity over 11β-HSD2. In mice, 25f was distributed to the target tissues

  基于结构的设计直接导致了1,3-恶二酮-2-酮9a在体外对11β-HSD1的IC 50为42 nM。优化9a以提高体外酶和细胞效能可得到25f，其酶的IC 50值为0.8 nM，而在脂肪细胞中的IC 50值为2.5 nM。另外，25f在大鼠中具有94％的口服生物利用度，并且相对于11β-HSD2具有> 1000倍的选择性。在小鼠中，将25f分配至靶组织，肝脏和脂肪，在食蟹猴中，口服10 mg / kg剂量的可的松攻击后，皮质醇的产生减少了85％。
• SUBSTITUTED FLUOROETHYL UREAS AS ALPHA 2 ADRENERGIC AGENTS
  申请人：Chow Ken

  公开号：US20080255239A1

  公开（公告）日：2008-10-16

  Therapeutic compounds, and methods, compositions, and medicaments related thereto are disclosed herein.

  本文揭示了治疗化合物、方法、组合物和相关药物。
• [EN] BICYCLIC AMIDE DERIVATIVES AND THEIR USE AS MUSCLE RELAXANTS<br/>[FR] DERIVES D'AMIDE BICYCLIQUE ET LEUR UTILISATION COMME RELAXANTS MUSCULAIRES
  申请人：THE WELLCOME FOUNDATION LIMITED

  公开号：WO1994026693A1

  公开（公告）日：1994-11-24

  (EN) Novel compounds of formula (I) together with their salts and solvates have a number of uses in medicine, in particular as central muscle relaxants.(FR) De nouveaux composés répondants à la formule (I), ainsi que leurs sels et solvats, conviennent à de nombreuses utilisations dans le domaine médical, en particulier comme relaxants des muscles centraux.

  (I)式的新化合物及其盐和溶剂化合物在医学上有许多用途，特别是作为中枢肌肉松弛剂。
• A new type of δ-vinylvalerolactone for palladium-catalyzed cycloaddition: synthesis of nine-membered heterocycles
  作者：Kuan Li、Sen Yang、Bing Zheng、Wei Wang、Yongjun Wu、Jing Li、Hongchao Guo

  DOI：10.1039/d2cc01134d

  日期：——

  In this paper, a new type of δ-vinylvalerolactone was designed and synthesized, and used as a new precursor in Pd-catalyzed [6+3] cycloaddition with azomethine imines, leading to nine-membered 1,2-dinitrogen-containing heterocycles in 77–98% yields with >20 : 1 d.r. These nine-membered ring-fused products were further transformed into unusual tetracyclic bridged-ring compounds without loss of the

  本文设计合成了一种新型的δ-乙烯基戊内酯，并作为新的前驱体用于Pd催化的[6+3]与偶氮甲亚胺的环加成反应，生成了9元1,2-含二氮杂环。 77–98% 产率，>20 : 1 dr 这些九元环稠合产物进一步转化为不寻常的四环桥环化合物，而不会损失非对映选择性。